Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00003
Species: Homo sapiens
Position : chr2:127082600-127082962
Year: 2019
Title: Brain cell type-specific enhancer-promoter interactome maps and disease-risk association.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: Alzheimer disease
PMID:  31727856
MONDO: MONDO:0004975
Tissue: brain
Tissue Ontology ID: UBERON:0000955
Cell Source: hPSC-derived microglia
Cell Type: Brain microglia
Experiment Type: CRISPR-Cas9 loss-of-function deletion, PLAC-seq chromatin interaction, ChIP-qPCR
High Throughput Method: ATAC-seq; H3K27ac ChIP-seq; H3K4me3 ChIP-seq; PLAC-seq; RNA-seq; LDSC GWAS heritability analysis
Low Throughput Method: qRT-PCR, dual-luciferase reporter,; RNA FISH super-resolution imaging, subcellular fractionation, xenograft in vivo tumor assay; Flow cytometry
About Target Gene
Target gene : BIN1
About TF
TF name : SPI1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
SPI1 C-MYB transcription factor network pid 87
SPI1 ERK cascade ( FGF8 signaling (Mouse) ) inoh 17
SPI1 ERK cascade ( FGF8 signaling (Xenopus) ) inoh 17
SPI1 FGF8 signaling pathway(Mouse) ( FGF8 signaling (Mouse) ) inoh 20
SPI1 FGF8 signaling pathway(Xenopus) ( FGF8 signaling (Xenopus) ) inoh 18
SPI1 Glucocorticoid receptor regulatory network pid 85
SPI1 IL4-mediated signaling events pid 66
SPI1 IL4 netpath 75
SPI1 Interleukin signaling pathway panther 86
SPI1 RANKL netpath 84
SPI1 Regulation of retinoblastoma protein pid 67
SPI1 Validated targets of C-MYC transcriptional repression pid 63
SPI1 Pathways in cancer kegg 321
SPI1 Acute myeloid leukemia kegg 53
SPI1 Hs_RANKL-RANK_(Receptor_activator_of_NFKB_(ligand))_Signaling_Pathway_WP2018_90016 wikipathways 26
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_00187 chr2:127082600-127082962 brain microglial cell Alzheimer disease
Expression of Target Genes for the Enhancer